Suppliers / Resilience Us

Resilience Us

United States Updated 9 July 2026

Resilience Us is a finished-dose manufacturer based in United States. It appears in 4 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with EMA, NCELS (KZ) and MPA (SE). Its GMP standing is certified by ANVISA (Brazil), NCELS (KZ) and US FDA. Its most recent recorded inspection, by US FDA, closed on 21 January 2025 as VAI.

0
active US DMFs
0
valid CEPs
2
registered plants 1 with an FDA FEI number
4
filings across 3 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 21 January 2025 VAI US FDA
  • 8 March 2018 VAI US FDA
  • 7 September 2017 NAI US FDA
  • 27 June 2017 NAI US FDA
  • 24 August 2016 NAI US FDA
  • 3 November 2015 NAI US FDA
  • 28 July 2015 NAI US FDA
  • 22 July 2014 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
WEST CHESTER, United States Not on file
West Chester, United States 3006316363

Filings and GMP by regulator

Regulator Filings GMP certificates
EMA 2 None
NCELS (KZ) 1 1
MPA (SE) 1 None
ANVISA (Brazil) None 3
US FDA None 1

Questions about Resilience Us

Does Resilience Us hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Resilience Us. It does have 4 filings with 3 regulators, so it is registered, just not with the two strong registers buyers usually screen on.
Is Resilience Us FDA-registered?
One site operated by Resilience Us carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Resilience Us's last inspection go?
The most recent inspection on record closed on 21 January 2025 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 8 inspections are on file.
Where does Resilience Us manufacture?
2 registered sites are on record, in United States (West Chester and West Chester). Every site is listed on this page with the register it came from.
Which regulators recognise Resilience Us's GMP?
Current GMP certificates are on record from ANVISA (Brazil), NCELS (KZ) and US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Resilience Us comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 21 January 2025.

Comparable suppliers

Aaa Pharmaceuticals also in United States Aarkish Pharmaceuticals NJ also in United States Abbott Laboratories also in United States Abon Pharmaceuticals also in United States Access Business Group also in United States

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates